logo
welcome
ScienceDaily

ScienceDaily

Candidate malaria vaccine provides lasting protection in NIH-sponsored trials

ScienceDaily
Summary
Nutrition label

82% Informative

Candidate malaria vaccine provides lasting protection in NIH -sponsored trials Approach could have role in preventing malaria in pregnancy.

Both dosages of the vaccine candidate conferred a significant degree of protection from parasite infection and clinical malaria that was sustained over a span of two years without the need for a booster dose -- a first for any malaria vaccine.

The Lancet Infectious Diseases , 2024 ; DOI: 10.01/10.00360-8 .

PfSPZ Vaccine is safe and effective against malaria in healthy adults and women anticipating pregnancy in Mali .

Vaccine can be given to pregnant women and pregnant women.

VR Score

92

Informative language

98

Neutral language

76

Article tone

formal

Language

English

Language complexity

77

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links